122 related articles for article (PubMed ID: 2380758)
1. 3H-thymidine-labeling index as a prognostic indicator in node-positive breast cancer.
Silvestrini R; Daidone MG; Valagussa P; Di Fronzo G; Mezzanotte G; Mariani L; Bonadonna G
J Clin Oncol; 1990 Aug; 8(8):1321-6. PubMed ID: 2380758
[TBL] [Abstract][Full Text] [Related]
2. Cell kinetics as a predictive factor in node-positive breast cancer treated with adjuvant hormone therapy.
Silvestrini R; Daidone MG; Mastore M; Di Fronzo G; Coradini D; Boracchi P; Squicciarini P; Salvadori B; Veronesi U
J Clin Oncol; 1993 Jun; 11(6):1150-5. PubMed ID: 8501501
[TBL] [Abstract][Full Text] [Related]
3. p53 as an independent prognostic marker in lymph node-negative breast cancer patients.
Silvestrini R; Benini E; Daidone MG; Veneroni S; Boracchi P; Cappelletti V; Di Fronzo G; Veronesi U
J Natl Cancer Inst; 1993 Jun; 85(12):965-70. PubMed ID: 8496982
[TBL] [Abstract][Full Text] [Related]
4. Identifying good prognosis group of breast cancer patients with 1-3 positive axillary nodes for adjuvant cyclophosphamide, methotrexate and 5-fluorouracil (CMF) chemotherapy.
Lin YC; Chen SC; Chang HK; Hsueh S; Tsai CS; Lo YF; Hwang TL; Chen MF
Jpn J Clin Oncol; 2005 Sep; 35(9):514-9. PubMed ID: 16199422
[TBL] [Abstract][Full Text] [Related]
5. Clinical relevance of vascular endothelial growth factor and thymidine phosphorylase in patients with node-positive breast cancer treated with either adjuvant chemotherapy or hormone therapy.
Gasparini G; Toi M; Miceli R; Vermeulen PB; Dittadi R; Biganzoli E; Morabito A; Fanelli M; Gatti C; Suzuki H; Tominaga T; Dirix LY; Gion M
Cancer J Sci Am; 1999; 5(2):101-11. PubMed ID: 10198732
[TBL] [Abstract][Full Text] [Related]
6. Prognostic significance of proliferative activity and ploidy in node-negative breast cancers.
Silvestrini R; Daidone MG; Del Bino G; Mastore M; Luisi A; Di Fronzo G; Boracchi P
Ann Oncol; 1993 Mar; 4(3):213-9. PubMed ID: 8471553
[TBL] [Abstract][Full Text] [Related]
7. Treatment of axillary lymph node-negative, estrogen receptor-negative breast cancer: updated findings from National Surgical Adjuvant Breast and Bowel Project clinical trials.
Fisher B; Jeong JH; Anderson S; Wolmark N
J Natl Cancer Inst; 2004 Dec; 96(24):1823-31. PubMed ID: 15601638
[TBL] [Abstract][Full Text] [Related]
8. Biologic and clinicopathologic factors as indicators of specific relapse types in node-negative breast cancer.
Silvestrini R; Daidone MG; Luisi A; Boracchi P; Mezzetti M; Di Fronzo G; Andreola S; Salvadori B; Veronesi U
J Clin Oncol; 1995 Mar; 13(3):697-704. PubMed ID: 7884430
[TBL] [Abstract][Full Text] [Related]
9. [Clinical characteristics and prognostic factors of female breast cancer patients with 10 or more positive lymph nodes: a report of 128 patients].
Guan Y; Xu BH; Li Q; Zhang P; Zhao LM; Yuan P; Wang JY
Zhonghua Yi Xue Za Zhi; 2008 Jan; 88(2):77-81. PubMed ID: 18353207
[TBL] [Abstract][Full Text] [Related]
10. Meta-analysis of adjuvant cyclophosphamide/methotrexate/5-fluorouracil chemotherapy in postmenopausal women with estrogen receptor-positive, node-positive breast cancer.
Hartman AR; Fleming GF; Dillon JJ
Clin Breast Cancer; 2001 Jul; 2(2):138-43; discussion 144. PubMed ID: 11899785
[TBL] [Abstract][Full Text] [Related]
11. Cell kinetics and hormonal features in relation to pathological stage in breast cancer.
Amadori D; Bonaguri C; Nanni O; Gentilini P; Lundi N; Zoli W; Riccobon A; Vio A; Magni E; Saragoni A
Breast Cancer Res Treat; 1991 Mar; 18(1):19-25. PubMed ID: 1854976
[TBL] [Abstract][Full Text] [Related]
12. Percent positive axillary lymph node metastasis predicts survival in patients with non-metastatic breast cancer.
Lale Atahan I; Yildiz F; Ozyigit G; Sari S; Gurkaynak M; Selek U; Hayran M
Acta Oncol; 2008; 47(2):232-8. PubMed ID: 17924207
[TBL] [Abstract][Full Text] [Related]
13. [Clinicopathological features and prognostic factors of breast cancer patients with inguinal lymph node metastases: a report of 17 cases].
Li Q; Xu BH; Zhang P; Li Q; Yuan P; Wang JY; Luo Y; Ma F; Fan Y; Li Q
Zhonghua Zhong Liu Za Zhi; 2013 Mar; 35(3):207-11. PubMed ID: 23880002
[TBL] [Abstract][Full Text] [Related]
14. Adjuvant chemotherapy with doxorubicin plus cyclophosphamide, methotrexate, and fluorouracil in the treatment of resectable breast cancer with more than three positive axillary nodes.
Buzzoni R; Bonadonna G; Valagussa P; Zambetti M
J Clin Oncol; 1991 Dec; 9(12):2134-40. PubMed ID: 1960555
[TBL] [Abstract][Full Text] [Related]
15. The Bcl-2 protein: a prognostic indicator strongly related to p53 protein in lymph node-negative breast cancer patients.
Silvestrini R; Veneroni S; Daidone MG; Benini E; Boracchi P; Mezzetti M; Di Fronzo G; Rilke F; Veronesi U
J Natl Cancer Inst; 1994 Apr; 86(7):499-504. PubMed ID: 8133533
[TBL] [Abstract][Full Text] [Related]
16. Goserelin versus cyclophosphamide, methotrexate, and fluorouracil as adjuvant therapy in premenopausal patients with node-positive breast cancer: The Zoladex Early Breast Cancer Research Association Study.
Jonat W; Kaufmann M; Sauerbrei W; Blamey R; Cuzick J; Namer M; Fogelman I; de Haes JC; de Matteis A; Stewart A; Eiermann W; Szakolczai I; Palmer M; Schumacher M; Geberth M; Lisboa B;
J Clin Oncol; 2002 Dec; 20(24):4628-35. PubMed ID: 12488406
[TBL] [Abstract][Full Text] [Related]
17. Cell kinetics as a prognostic indicator in node-negative breast cancer.
Silvestrini R; Daidone MG; Valagussa P; Di Fronzo G; Mezzanotte G; Bonadonna G
Eur J Cancer Clin Oncol; 1989 Aug; 25(8):1165-71. PubMed ID: 2767105
[TBL] [Abstract][Full Text] [Related]
18. Cell kinetics: an independent prognostic variable in stage II melanoma of the skin.
Costa A; Silvestrini R; Mezzanotte G; Vaglini M; Grignolio E; Clemente C; Cascinelli N
Br J Cancer; 1990 Nov; 62(5):826-9. PubMed ID: 2245175
[TBL] [Abstract][Full Text] [Related]
19. Randomized cooperative study of perioperative chemotherapy in breast cancer.
Sertoli MR; Bruzzi P; Pronzato P; Queirolo P; Amoroso D; Del Mastro L; Venturini M; Vigani A; Bertelli G; Campora E
J Clin Oncol; 1995 Nov; 13(11):2712-21. PubMed ID: 7595729
[TBL] [Abstract][Full Text] [Related]
20. Proliferative activity of primary breast cancer and of synchronous lymph node metastases evaluated by [3H]-thymidine labelling index.
Daidone MG; Silvestrini R; Valentinis B; Persici P; Mezzanotte G; Squicciarini P; Orefice S; Salvadori B
Cell Tissue Kinet; 1990 Sep; 23(5):401-8. PubMed ID: 2245439
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
